Dirk Hasenclever (D Hasenclever)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Replacement Therapy

Kidney Transplantation

Hodgkin Lymphoma

Top Venues

Human reproduction (Oxford, England)

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Katja C E Drechsel, Simone L Broer, Francis Stoutjesdijk, Eline Van Dulmen-den Broeder, Auke Beishuizen, William Hamish B Wallace, D Körholz, Christine Mauz-Körholz, Dirk Hasenclever, Cepelova Michaela, Anne Uyttebroeck, L Ronceray, Jos W R Twisk, Gertjan J L Kaspers, Margreet A Veening
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone. Human reproduction (Oxford, England) (2024)
Katja C E Drechsel, Simone L Broer, Francis Stoutjesdijk, Eline Van Dulmen-den Broeder, Auke Beishuizen, William Hamish B Wallace, D Körholz, Christine Mauz-Körholz, Dirk Hasenclever, Cepelova Michaela, Anne Uyttebroeck, L Ronceray, Jos W R Twisk, Gertjan J L Kaspers, Margreet A Veening
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone. Human reproduction (Oxford, England) 39 (8) (2024)
Vanessa C Marsano, Dirk Hasenclever, Reinhard Henschler
The effectiveness of telephone surveys on the return of first-time donors: A randomized controlled trial. Transfusion (2024)
Katja C E Drechsel, Simone L Broer, Francis Stoutjesdijk, Eline Van Dulmen-den Broeder, Auke Beishuizen, William Hamish B Wallace, D Körholz, Christine Mauz-Körholz, Dirk Hasenclever, Cepelova Michaela, Anne Uyttebroeck, L Ronceray, Jos W R Twisk, Gertjan J L Kaspers, Margreet A Veening
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone. Human reproduction (Oxford, England) 39 (8) (2024)
Katja C E Drechsel, Simone L Broer, Francis Stoutjesdijk, Eline Van Dulmen-den Broeder, Auke Beishuizen, William Hamish B Wallace, D Körholz, Christine Mauz-Körholz, Dirk Hasenclever, Cepelova Michaela, Anne Uyttebroeck, L Ronceray, Jos W R Twisk, Gertjan J L Kaspers, Margreet A Veening
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone. Human reproduction (Oxford, England) 39 (8) (2024)
Katja C E Drechsel, Simone L Broer, H M K van Breda, Francis Stoutjesdijk, Eline Van Dulmen-den Broeder, Auke Beishuizen, William Hamish B Wallace, D Körholz, Christine Mauz-Körholz, Dirk Hasenclever, Cepelova Michaela, Anne Uyttebroeck, L Ronceray, Jos W R Twisk, Gertjan J L Kaspers, Margreet A Veening
Semen analysis and reproductive hormones in boys with classical Hodgkin lymphoma treated according to the EuroNet-PHL-C2 protocol. Human reproduction (Oxford, England) (2024)
Ila Motmaen, Sergej Sereda, Alexander Brobeil, Ananth Shankar, Andreas Braeuninger, Dirk Hasenclever, Stefan Gattenlöhner
Deep-learning based classification of a tumor marker for prognosis on Hodgkin's disease. European journal of haematology (2023)
Linda Tanner, Simone Lindau, Markus Velten, Tobias Schlesinger, Wittmann Maria, Peter Kranke, Kira Berg, Florian Piekarski, Christoph Füllenbach, Suma Choorapoikayil, Dirk Hasenclever, Kai Zacharowski, Patrick Meybohm
Factors influencing the bias between blood gas analysis versus central laboratory hemoglobin testing. A secondary analysis of a randomized controlled trial. PloS one 15 (10) (2020)
Thomas Walter Georgi, Lars Kurch, Dirk Hasenclever, Victoria S Warbey, Lucy C Pike, John Radford, Osama Sabri, Regine Kluge, Sally F Barrington
Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial. PloS one 15 (4) (2020)